Skip to main content

RETRACTION article

Front. Immunol., 25 October 2024
Sec. Inflammation
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1513350
This article is part of the Research Topic Characteristic clinical immune phenotypes and molecular mechanisms associated with inflammatory diseases View all 26 articles

Retraction: Tregs depletion aggravates activation of astrocytes by modulating IL-10/GXP4 following cerebral infarction

This article is a retraction of:

  1. RETRACTED: Tregs depletion aggravates activation of astrocytes by modulating IL-10/GXP4 following cerebral infarction

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original Research Article
    Tregs depletion aggravates activation of astrocytes by modulating IL-10/GXP4 following cerebral infarction

    By Wang S, Shi Y, Zhang Y, Yuan F, Mao M and Ma J (2023) Tregs depletion aggravates activation of astrocytes by modulating IL-10/GXP4 following cerebral infarction. Front. Immunol. 14:1255316. doi: 10.3389/fimmu.2023.1255316

    The journal retracts the 2023 article cited above.

    Following publication, concerns were raised regarding inaccuracies in several sections of the article. The raw data and materials provided by the authors were incomplete and contained errors, not allowing for the results to be reproduced. Further assessment by the Chief Editor led to the conclusion that the article would require an extensive number of corrections that would substantially modify the content from the version assessed during peer review, as the article’s conclusions and assertions are not sufficiently supported by the findings from the material provided. Therefore, the article has been retracted.

    This retraction was approved by the Chief Editor of Frontiers in Immunology and the Chief Executive Editor of Frontiers.

    Citation: Frontiers Editorial Office (2024) Retraction: Tregs depletion aggravates activation of astrocytes by modulating IL-10/GXP4 following cerebral infarction. Front. Immunol. 15:1513350. doi: 10.3389/fimmu.2024.1513350

    Received: 18 October 2024; Accepted: 18 October 2024;
    Published: 25 October 2024.

    Approved by:

    Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

    Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.